
Akebia Therapeutics Inc (AKBA) with a beta value of 0.97 appears to be a promising investment opportunity.
Akebia Therapeutics Inc (NASDAQ: AKBA) kicked off on Tuesday, up 0.26% from the previous trading day, before settling in for the closing price of $3.84.